Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

186
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
186
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.2K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.2K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.0K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

472
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
472
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

13.4K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
13.4K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

54
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
54

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic reprogramming of CD4⁺ T cells by Zaprinast induces HIV-1 latency reversal ex vivo.

Retrovirology·2026
Same author

Evaluating trastuzumab deruxtecan in patients with gastrooesophageal adenocarcinoma who are ctDNA and HER2 positive: DECIPHER.

ESMO gastrointestinal oncology·2026
Same author

A review of current and potential applications of macroalgae to equine veterinary science.

Journal of equine veterinary science·2025
Same author

The Global Epidemic of Young Onset Colorectal Cancer has Arrived - Implications for Irish Healthcare.

Irish medical journal·2025
Same author

An Investigation into Fertility Awareness and Attitudes amongst Midwives and Nurses.

Irish medical journal·2025
Same author

CTRIAL-IE (ICORG) 15-34: The impact of the 21 gene breast recurrence score® assay on chemotherapy prescribing in oestrogen receptor positive, lymph node positive early stage breast cancer in Ireland.

Irish journal of medical science·2025
Same journal

Unlocking the potential of electronic health records for research purposes.

Irish medical journal·2026
Same journal

ICU Handover: A Persistent Vulnerability in Critical Care Settings.

Irish medical journal·2026
Same journal

The Sugar-Sweetened Beverage Tax (Sugar Tax): Innovation and Stasis.

Irish medical journal·2026
Same journal

Gastrointestinal trichobezoars presenting as abdominal pain and obstruction - Rapunzel syndrome.

Irish medical journal·2026
Same journal

When Sepsis Kills: A Fatal Cascade of Invasive Group A Streptococcal Sepsis.

Irish medical journal·2026
Same journal

Fulminant Thrombotic Thrombocytopenic Purpura presenting through the FAST Stroke Pathway.

Irish medical journal·2026
See all related articles

Related Experiment Video

Updated: Sep 27, 2025

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

46.9K

Secondary Risk Reduction Strategies in Breast Cancer Care.

C Steele1, S O'Reilly2

  • 1School of Medicine, University College Cork, Ireland.

Irish Medical Journal
|April 13, 2022
PubMed
Summary
This summary is machine-generated.

Improved breast cancer survival necessitates integrating secondary risk reduction strategies into routine care. This proactive approach addresses increased risks of other cancers and cardiovascular disease in survivors.

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

400

Related Experiment Videos

Last Updated: Sep 27, 2025

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

46.9K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

400

Area of Science:

  • Oncology
  • Public Health
  • Preventive Medicine

Background:

  • Breast cancer survival rates have significantly improved over the last 30 years due to advancements in diagnostics and therapeutics.
  • Increased survival means patients are now at higher risk for secondary cancers and non-communicable diseases, including cardiovascular disease.
  • Current cardiovascular disease management includes secondary risk reduction strategies.

Purpose of the Study:

  • To advocate for the integration of secondary risk reduction strategies into standard early-stage breast cancer care.
  • To present evidence supporting a proactive approach to managing long-term health risks in breast cancer survivors.

Main Methods:

  • Review of current evidence on breast cancer survivorship and associated health risks.
  • Analysis of the efficacy of secondary risk reduction strategies in managing non-communicable diseases.
  • Comparative analysis of current cardiovascular disease management protocols.

Main Results:

  • Breast cancer survivors face elevated risks of developing other cancers and cardiovascular disease.
  • Secondary risk reduction strategies are effective in managing cardiovascular disease.
  • Evidence supports the applicability of these strategies to breast cancer survivorship.

Conclusions:

  • Integrating secondary risk reduction strategies into early-stage breast cancer treatment plans is crucial.
  • This integration can mitigate long-term health risks and improve overall patient outcomes.
  • A standard of care incorporating these strategies is recommended for breast cancer patients.